Related Experiment Video
Updated: Jan 16, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Graft Characteristics to Optimize Outcomes in Pediatric Liver Transplantation
Seisuke Sakamoto1, Mureo Kasahara1
1Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
Insights
Optimizing pediatric liver transplantation (LT) involves careful graft selection and procurement. Strategies like living donor liver transplantation (LDLT) and split deceased donor liver transplantation (DDLT) expand donor options and reduce waitlist deaths.
Area of Science:
- Pediatric Surgery
- Transplantation Immunology
- Hepatology
Background:
- Pediatric liver transplantation (LT) is a critical treatment for end-stage liver disease in children.
- Living donor liver transplantation (LDLT) and split deceased donor liver transplantation (DDLT) are key strategies to expand the donor pool and reduce waitlist mortality.
Purpose of the Study:
- To review current literature on optimizing graft selection and procurement for pediatric LT.
- To delineate principles and measures for selecting and procuring high-quality grafts.
Main Methods:
- Analysis of graft characteristics, including size matching, donor/graft quality, and procurement procedures.
- Review of literature on optimizing outcomes in pediatric LT.
Main Results:
- Studies have clarified "small-for-size" and "large-for-size" graft issues in LDLT.
- Refined techniques for reduced left lateral segment grafts are suitable for small children.
- Overcoming barriers with ABO-incompatible, hepatitis B core antibody-positive, and genetically diverse parental donors has enabled successful LDLT.
- Machine perfusion shows promise for optimizing extended criteria donor organs.
Conclusions:
- A multidisciplinary approach combining DDLT and LDLT advantages is essential for optimal pediatric LT outcomes.
- Minimally invasive donor hepatectomy is crucial for donor safety and graft quality.
Background:
Various efforts have been made to optimize the outcomes of pediatric liver transplantation (LT), which has become an established treatment for end-stage liver disease in children. Living donor liver transplantation (LDLT) and split deceased donor liver transplantation (DDLT) could increase the donor pool for children to dramatically reduce pretransplant waitlist mortality.
Methods:
Graft characteristics to optimize the outcomes in pediatric LT have been analyzed from various aspects, including graft size matching, donor/graft quality, and graft procurement procedure. This special article reviews the current literature and delineates the principles/measures to make an appropriate graft selection and the graft procurement to obtain good-quality grafts.
Results:
Several studies related to graft size matching in LDLT have elucidated the pathogenesis of "small-for-size" and "large-for-size" issues. The procedures used to make reduced left lateral segment grafts have been technically refined, and these grafts are widely applicable for small children. The livers from ABO-incompatible donors, hepatitis B core antibody-positive donors, and parental donors with a background of congenital inherited genetic disorders have been successfully transplanted into children by overcoming each barrier, and these livers are widely used in LDLT. Machine perfusion is a promising modality to optimize the extended criteria donor organs with outcomes comparable to those of good-quality grafts.
Conclusion:
A multidisciplinary approach, leveraging each advantage between DDLT and LDLT, is going to achieve the best outcomes in the field of pediatric LT. In addition, minimally invasive donor hepatectomy must be promoted to guarantee donor safety without compromising graft quality.
Related Concept Videos
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

